The Diurnal Rhythm in Natriuretic Peptide Levels
NCT03834168 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 42
Last updated 2024-02-05
Summary
The purpose of the study to assess the diurnal rhythm in natriuretic peptide levels and its temporal relationship with nocturnal blood pressure in obese and African-American individuals as compared with lean and white individuals.
Conditions
- Natriuretic Peptides
- Obesity
- Nocturnal Blood Pressure
Interventions
- OTHER
-
standardized Study Diet
Standardized diet consisted with eucaloric meals with 4.5 gm of sodium per day for 5 days.
Sponsors & Collaborators
-
University of Alabama at Birmingham
lead OTHER
Principal Investigators
-
Pankaj Arora, MD · University of Alabama at Birmingham
-
Orlando M Gutierrez, MMSc · University of Alabama at Birmingham
Study Design
- Allocation
- NA
- Purpose
- OTHER
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 40 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2019-04-01
- Primary Completion
- 2020-02-29
- Completion
- 2021-03-31
Countries
- United States
Study Locations
More Related Trials
-
The Natriuretic Peptide System in African-Americans.
NCT02730780 ·Status: COMPLETED ·Phase: NA
-
The Natriuretic Peptide Response to Saline Infusion
NCT04223531 ·Status: COMPLETED ·Phase: NA
-
Diurnal BP Patterns in Those at Increased Risk of CVD
NCT04522765 ·Status: RECRUITING
-
Metabolic Effects of Natriuretic Peptide Hormones
NCT03397966 ·Status: TERMINATED ·Phase: PHASE4
-
Vascular Responses to Sympathetic Activation and Altered Shear Rate: The Impact of Hypertension and Sodium Intake
NCT03558022 ·Status: COMPLETED ·Phase: NA
-
A Biomarker to Detect Salt Sensitivity
NCT03147170 ·Status: COMPLETED
-
Natriuretic Peptide System as Therapy in Human Preclinical Left Ventricle Dysfunction
NCT00387621 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effect of Intense vs. Standard Hypertension Management on Nighttime Blood Pressure - an Ancillary Study to SPRINT
NCT01835249 ·Status: COMPLETED ·Phase: NA
-
Natriuretic Peptides and Metabolic Risk in Obesity
NCT02642523 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
Relationship of Urine Sodium Excretion to Central Blood Pressure and Aortic Pulse Wave Velocity
NCT01237717 ·Status: COMPLETED
-
Effects of the Dietary Approaches to Stop Hypertension(DASH) Sodium-restricted Diet in Diastolic Heart Failure
NCT00939640 ·Status: COMPLETED ·Phase: NA
-
Mechanisms of Refractory Hypertension (High and Low Salt Diet)
NCT02357017 ·Status: WITHDRAWN ·Phase: NA
-
Blood Pressure Response to Sodium in the Diet
NCT01899495 ·Status: UNKNOWN ·Phase: NA
-
Nocturnal Blood Pressure and Hypertension - Central and Peripheral 24-h Blood Pressure.
NCT02078765 ·Status: UNKNOWN
-
Long-term of Remote Ischemic Preconditioning and Mindfulness in Patients With Mild Hypertension
NCT04753840 ·Status: RECRUITING ·Phase: NA
-
Mechanisms Underlying Abnormal Ambulatory BP Patterns
NCT00005346 ·Status: COMPLETED
-
The Effect of High and Low Sodium Intake on Urinary Aquaporin-2 in Essential Hypertension
NCT00345124 ·Status: COMPLETED ·Phase: NA
-
Oral Sodium Blood Pressure in Normal Weight, Overweight and Obese Volunteers
NCT01532401 ·Status: COMPLETED ·Phase: PHASE2
-
Nocturnal Blood Pressure Dipping and Ventricular Repolarization in Hypertension
NCT07200856 ·Status: NOT_YET_RECRUITING
-
Dapagliflozin on Blood Pressure Variability and Ambulatory Arterial Stiffness Index in Hypertension
NCT03592667 ·Status: UNKNOWN ·Phase: PHASE4
-
CARDIA-Salt Sensitivity of Blood Pressure (SSBP)
NCT04258332 ·Status: COMPLETED ·Phase: NA
-
Effect of Anti-hypertensive Medications on the Diagnostic Accuracy in Primary Aldosteronism
NCT04991961 ·Status: COMPLETED
-
Sodium, Nocturnal Blood Pressure and Nocturnal Pauses in Breathing
NCT06022133 ·Status: COMPLETED ·Phase: NA
-
Aldosterone, Microvascular Function and Salt-sensitivity
NCT02068781 ·Status: COMPLETED ·Phase: NA
-
Dietary Sodium Intake in Acute Heart Failure
NCT03722069 ·Status: COMPLETED ·Phase: NA